Comparative Benchmarking
In the context of the broader market, TLX competes directly with industry leaders such as CRSP and TWST. With a market capitalization of $3.98B, it holds a significant position in the sector. When comparing efficiency, TLX's gross margin of N/A stands against CRSP's 100.00% and TWST's 51.59%. Such benchmarking helps identify whether Telix Pharmaceuticals Ltd is trading at a premium or discount relative to its financial performance.
